Fundraising Fox

Vir

4 known investors

Vir Biotechnology develops treatments for infectious diseases and oncology, leveraging immunology-focused scientific capabilities. The company targets patients with unmet medical needs across these therapeutic areas.

AI & Machine LearningBiotechDigital HealthMedical Devicesin /vir-biotechnology-inc.@Vir_Biotech

Founders & leadership

MD

Marianne De BackerCEO

Investors · 4

Alta PartnersJackson · $1M – $12M

ARCH Venture PartnersChicago · $50K – $250M

8VCreportedAustin · $100K – $50M

SoftBank GroupreportedTokyo

In the news

Hillsdale Investment Management Inc. Invests $1.44 Million in Vir Biotechnology, Inc. $VIRmarketbeat.com · 2026
Vir Biotechnology Raises Capital Through Public Stock Offering - The Globe and Mailtheglobeandmail.com · 2026
Vir Biotech gets U.S. funding for flu-prevention antibody | Reutersreuters.com · 2022
SoftBank-backed Vir Biotechnology raises $143 million in U.S. IPO | Reutersreuters.com · 2019